Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6857 Lung Neoplasms 5091 Small Cell Lung Carcinoma 1162 Breast Neoplasms 854 Neoplasms 762 Colorectal Neoplasms 664 Melanoma 566 Ovarian Neoplasms 505 Neoplasm Metastasis 480 Pancreatic Neoplasms 472 Stomach Neoplasms 396 Adenocarcinoma of Lung 396 Prostatic Neoplasms 369 Head and Neck Neoplasms 366 Carcinoma, Renal Cell 349 Esophageal Neoplasms 336 Mesothelioma, Malignant 324 Squamous Cell Carcinoma of Head and Neck 323 Colonic Neoplasms 293 Mesothelioma 289 Urinary Bladder Neoplasms 262 Brain Neoplasms 253 Uterine Cervical Neoplasms 241 Triple Negative Breast Neoplasms 220 Sarcoma 197 Endometrial Neoplasms 195 Carcinoma, Hepatocellular 185 NSCLC 165 Kidney Neoplasms 160 Pleural Effusion, Malignant 159

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable Non-Small Cell Lung Cancer × Thoracic × Clear all

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡